1. Home
  2. NWBI vs NUVB Comparison

NWBI vs NUVB Comparison

Compare NWBI & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northwest Bancshares Inc.

NWBI

Northwest Bancshares Inc.

HOLD

Current Price

$15.59

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$6.44

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWBI
NUVB
Founded
1896
2018
Country
United States
United States
Employees
N/A
307
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
NWBI
NUVB
Price
$15.59
$6.44
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$14.50
$11.38
AVG Volume (30 Days)
1.1M
6.1M
Earning Date
04-27-2026
05-04-2026
Dividend Yield
5.82%
N/A
EPS Growth
16.46
N/A
EPS
0.71
N/A
Revenue
N/A
N/A
Revenue This Year
$6.29
$203.82
Revenue Next Year
$5.06
$58.18
P/E Ratio
$22.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.25
$2.18
52 Week High
$16.16
$9.75

Technical Indicators

Market Signals
Indicator
NWBI
NUVB
Relative Strength Index (RSI) 56.27 49.95
Support Level $15.07 $5.28
Resistance Level $16.16 $6.13
Average True Range (ATR) 0.23 0.39
MACD -0.00 -0.06
Stochastic Oscillator 53.21 27.03

Price Performance

Historical Comparison
NWBI
NUVB

About NWBI Northwest Bancshares Inc.

Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: